ProjectOTL-200-10 – Long-term Efficacy and Safety follow-up of MLD Patients treated with atidarsagene autotemcel

Basic data

Acronym:
OTL-200-10
Title:
Long-term Efficacy and Safety follow-up of MLD Patients treated with atidarsagene autotemcel
Duration:
01/07/2024 to 01/07/2024
Abstract / short description:
An observational study to describe outcome after treatment with atidarsagene autotemcel

Involved staff

Managers

Faculty of Medicine
University of Tübingen
Faculty of Medicine
University of Tübingen

Contact persons

Faculty of Medicine
University of Tübingen

Local organizational units

University Children’s Hospital - Department of Paediatrics
Hospitals and clinical institutes
Faculty of Medicine

Funders

London, United Kingdom
Help

will be deleted permanently. This cannot be undone.